Medicus Pharma Ltd. Common Stock
MDCX | NASDAQ
$0.50
$0.00 (0.00%)
Nov 2, 2026, 12:30 PM ET · Market open
Company Profile
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.
Key Executives
| Name | Position |
|---|---|
| Raza Bokhari | Chief Executive Officer & Executive Chairman |
| Andrew Alasdair Smith | Chief Operating Officer |
| James Quinlan | Chief Financial Officer (Leave of Absence) |
| Anna Baran-Djokovic | Senior Vice President of Investor Relations |
| Edward J. Brennan Jr. | Chief Scientific Officer and Head of R&D Program |
| Faisal Mehmud | Chief Medical Officer |
| Maryann Adesso | Chief of Staff & Corporate Secretary |
| Viktoria Slepeniuk | Senior Vice President of Public Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 04, 2026 | EFFECT | Filing |
| Jan 30, 2026 | S-3 | Filing |
| Jan 05, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 02, 2026 | 424B5 | Filing |
| Dec 31, 2025 | EFFECT | Filing |
| Dec 30, 2025 | 424B3 | Filing |
| Dec 30, 2025 | 424B3 | Filing |
| Dec 30, 2025 | 424B3 | Filing |
| Dec 30, 2025 | 424B3 | Filing |
| Dec 30, 2025 | 253G2 | Filing |
Medicus Pharma Ltd. Common Stock
| Country | Canada |
| IPO Date | Nov 15, 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 12 |
| CEO | Raza Bokhari |
Contact Details
300 Conshohocken State Rd. Suite 200 W. Conshohocken 19428 Canada
Stock Details
| Ticker Symbol | MDCX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001997296 |
| CUSIP Number | n/a |
| ISIN Number | CA58471K2020 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove MDCX